You can buy or sell MRKR and other stocks, options, ETFs, and crypto commission-free!
Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Read More The company was founded on October 22, 1991 and is headquartered in Houston, TX.
52 Week High
52 Week Low
— per share
Expected May 7, After Hours